Sequence-specific modification of genomic DNA by small DNA fragments
- PMID: 12952908
- PMCID: PMC182219
- DOI: 10.1172/JCI19773
Sequence-specific modification of genomic DNA by small DNA fragments
Abstract
Small DNA fragments have been used to modify endogenous genomic DNA in both human and mouse cells. This strategy for sequence-specific modification or genomic editing, known as small-fragment homologous replacement (SFHR), has yet to be characterized in terms of its underlying mechanisms. Genotypic and phenotypic analyses following SFHR have shown specific modification of disease-causing genetic loci associated with cystic fibrosis, beta-thalassemia, and Duchenne muscular dystrophy, suggesting that SFHR has potential as a therapeutic modality for the treatment of monogenic inherited disease.
Figures
References
-
- Friedmann T. Progress toward human gene therapy. Science. 1989;244:1275–1281. - PubMed
-
- Friedmann T. A brief history of gene therapy. Nat. Genet. 1992;2:93–98. - PubMed
-
- Marshall E. Gene therapy’s growing pains. Science. 1995;269:1050–1055. - PubMed
-
- Summary table: human gene therapy protocols, last updated: 8/10/01. Hum. Gene Ther. 2001;12:2019–2020.
-
- Gene therapy clinical trials. The Journal of Gene Medicine. http://www.wiley.co.uk/genetherapy/clinical/.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
